CRISPR Therapeutics
CRSP
#3113
Rank
HK$30.79 B
Marketcap
HK$360.80
Share price
-1.90%
Change (1 day)
-35.85%
Change (1 year)

CRISPR Therapeutics (CRSP) Fails to deliver data

Key failure to deliver metrics for CRISPR Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for CRISPR Therapeutics (CRSP) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for CRISPR Therapeutics (CRSP) - since 2016

Volume in USD (price x number of shares), data since 2016

CRISPR Therapeutics (CRSP) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024HK$0.13 B-11.07%
2023HK$0.14 B1.4%
2022HK$0.14 B8.89%
2021HK$0.13 B22.76%
2020HK$0.10 B-2.51%
2019HK$0.11 B59.97%
2018HK$70.19 M265.26%
2017HK$19.21 M319.28%
2016HK$4.58 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
HK$1.5 MHK$5.99 M๐Ÿ‡บ๐Ÿ‡ธ USA